80% of liver cancer patients have the history of hepatitis B

“Liver cancer patients 80% -90% basis of a hepatitis B, hepatitis B and liver cancer and a clear relationship.” Recently, in order to allow the general public understand the normative treatment of hepatitis B and hepatitis B treatment of attention problems, the Guangdong Provincial People Hepatitis B prevention and treatment at the hospital special briefings. During the seminar, experts pointed out that most of the treatment of hepatitis B virus carriers do not have to, but that does not mean a free hand regardless of the lack of regular checks on the clinical symptoms of many patients once it is cirrhosis, liver cancer or even the. Guangdong Provincial People’s Hospital of director Chen Xiao-ping said that many of China’s chronic hepatitis B infection in infants and young children during or caused by maternal and child vertical transmission. According to reports, China’s some 120 million hepatitis B virus carriers, of which 30 million people can become chronic hepatitis, cirrhosis or liver cancer.

Chen Xiao-ping said that the majority of hepatitis B virus carriers do not have treatment, but that does not mean that all the hepatitis B virus carriers are safe, can sit back and relax. “Some carriers do not attach importance to regular inspections, wait until symptoms appear before medical treatment, liver disease often is advanced, treatment may lose the opportunity.” Chen Xiao-ping, the clinical statistics show that liver cancer patients from 80 to 90 percent are B Liver basis.

Hepatitis B virus carriers how to develop their own inspection program » What are the hepatitis B patients in need of treatment »

Chen Xiao-ping pointed out that hepatitis B carriers into two categories: First, chronic hepatitis B virus carriers, the activities of non-performance of antigen carriers. The former includes, Xiao Sanyang patients, serum hepatitis B virus (HBVDNA) were positive, “such patients need every three months regularly checked.” Second category of patients, including Xiao Sanyang, HBVDNA negative patients, By doctors as “good carriers,” six months to check again.

It is understood that in addition to the above two types of carriers, Chen Xiao-ping stressed that in chronic hepatitis B virus carriers, although some patients with normal liver function performance, but the actual liver inflammation has been more pronounced, and even liver fibrosis, such Patients of the carriers from 20 to 50 percent, “this type of person who does not timely treatment, and faster development of liver cirrhosis or even liver cancer.” Chen Xiao-ping suggested that such serum HBV carriers if the continuing high level In 105 copies / ml and above, should be carried out liver puncture inspection, the next step to assist in the treatment.


You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply